Alian, s.r.o.

Bardejov, Slovak Republic 08501

0 studies enrolling now · 2 studies all time

What they study most

Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed